Abbott India (BOM:500488) Cyclically Adjusted PB Ratio: (As of Aug. 25, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:500488 Abbott India Ltd BOM:500488
87 GF Score
Price ₹26,415.85
GF Value ₹32,412.89
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Abbott India Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Abbott India  (BOM:500488) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Abbott India Cyclically Adjusted PB Ratio Related Terms


Abbott India Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Abbott India's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott India Cyclically Adjusted PB Ratio Chart

Abbott India Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.55 21.55 22.99 23.36 17.35

Abbott India Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 20.77 0.00 17.35 0.00

BOM:500488 vs ZTS: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Abbott India's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott India Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott India's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Abbott India's Cyclically Adjusted PB Ratio falls into.


BOM:500488
87GF Score
Abbott India Ltd BOM:500488
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott India Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Abbott India's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Abbott India's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0/167.3573*167.3573
=0.000

Current CPI (Jun. 2026) = 167.3573.

Abbott India Quarterly Data

Book Value per Share CPI Adj_Book
201609 591.331 105.961 933.961
201612 0.000 105.196 0.000
201703 652.710 105.196 1,038.402
201706 0.000 107.109 0.000
201709 693.383 109.021 1,064.403
201712 0.000 109.404 0.000
201803 796.630 109.786 1,214.375
201806 0.000 111.317 0.000
201809 835.861 115.142 1,214.913
201812 0.000 115.142 0.000
201903 945.261 118.202 1,338.355
201906 0.000 120.880 0.000
201909 1,003.511 123.175 1,363.466
201912 0.000 126.235 0.000
202003 1,144.383 124.705 1,535.790
202006 0.000 127.000 0.000
202009 1,064.709 130.118 1,369.426
202012 0.000 130.889 0.000
202103 1,224.604 131.771 1,555.329
202106 0.000 134.084 0.000
202109 1,133.653 135.847 1,396.609
202112 0.000 138.161 0.000
202203 1,327.022 138.822 1,599.798
202206 0.000 142.347 0.000
202209 1,277.467 144.661 1,477.892
202212 0.000 145.763 0.000
202303 1,500.560 146.865 1,709.940
202306 0.000 150.280 0.000
202309 1,463.090 151.492 1,616.315
202312 0.000 152.924 0.000
202403 1,740.736 153.035 1,903.655
202406 0.000 155.789 0.000
202409 1,657.071 157.882 1,756.518
202412 0.000 158.323 0.000
202503 1,992.164 157.552 2,116.151
202506 0.000 159.755 0.000
202509 1,887.576 162.289 1,946.523
202512 0.000 163.281 0.000
202603 2,246.783 164.272 2,288.976
202606 0.000 167.357 0.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Abbott India (BOM:500488) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott India stock appears to be undervalued. The current stock price of ₹26,415.85 is trading 18.5% below its estimated GF Value™ of ₹32,412.89. GuruFocus considers Abbott India to be Modestly Undervalued.

Key valuation signals for BOM:500488:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: ₹32,412.89 vs. price of ₹26,415.85 (18.5% below fair value)
  • GF Score™: 87/100 with 1 warning sign

No single metric tells the full story. See the BOM:500488 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Abbott India Business Description

Other Exchanges ABBOTINDIA:India
Address Plot C-68, G Block, 16th Floor, Godrej BKC, Near MCA Club, Bandra-Kurla Complex, Bandra (East), Mumbai, MH, IND, 400051
Abbott India Ltd is a drug manufacturing company that offers products in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. Its patient focus centers overwhelmingly on women's health and gastrointestine, gastroenterology, and hepatic care. Geographically, the majority of the company's revenue is generated in India.
87GF Score

Get the complete analysis for BOM:500488

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹26,415.85
Price
₹32,412.89
GF Value